TLDRocket
Sign in

Beyond AI scribes: Aisel raises €1.7M to tackle psychiatry’s capacity crisis

Tech.eu Cate Lawrence Covered by 2 sources

Aisel raised €1.7M to build AI for psychiatry, not just note-taking. It wants clinicians to understand patients faster, cutting long waits.

Based on reporting by Tech.eu, Cate Lawrence — read the original for the full story.

Summary, retelling and take written by AI under human oversight; images are AI-generated illustrations. How we work · Report an error

Aisel Health, a Danish company building what it calls an operating system for psychiatry, has closed a €1.7 million pre-seed round. Caesar Ventures led the raise, with Nordic Web Ventures, LifeX and Angel Invest joining alongside existing backers Rockstart and EIFO. Co-founder and Chief Product Officer Christian Houen frames the stakes bluntly: mental healthcare has been underfunded and overlooked for years, and waiting lists are, in his words, on the brink of catastrophe.

Most of the AI activity in clinical settings right now is scribing — tools that transcribe consultations and spit out faster notes. Houen doesn't dispute that these work. But he argues they solve the wrong problem. Cheaper, faster documentation just produces more documentation, and clinicians still have to wade through it before the next appointment. Nothing about a quicker note fixes the moment when a patient returns and has to repeat information already buried somewhere in their file. Aisel's pitch is that the real constraint isn't writing things down, it's making sense of what's already been written.

That framing is backed by Aisel's own research, published as "The Documentation Minute," which found psychiatrists spend only around 40 per cent of their time actually with patients. The rest goes into reading, gathering history from referrals and prior notes, and writing it all up. Aisel's platform tries to compress that by turning recordings, existing documents and patient accounts into what Houen calls a "sphere of understanding" — a running, contextual picture of each patient that grows over time and surfaces the relevant facts, with sources and citations, right before a clinician needs them.

The company has also pushed its intake technology further than it had a year ago. In ADHD diagnostic workflows, for instance, Aisel can send AI-driven interviews not just to patients but to relatives, schools and other parties, folding their input into the same shared record. Houen points to a pilot with a children's clinic as the clearest case for this: kids alone can't provide a full picture, and the manual process of chasing down parents and teachers by phone has historically been one reason child and youth psychiatry waiting times stretch out. To check the approach actually works, Aisel initially ran it alongside clinics' existing methods, comparing outputs and using blind reviews, and now tracks response rates plus clinician and patient satisfaction.

Aisel isn't stopping at patient history. Houen describes ambitions to smooth clinic operations more broadly — rebooking appointments, managing medication, sorting prescriptions — tasks he says often fall through the cracks between doctor and secretary, leaving patients to discover weeks later that the next slot is six weeks out. Caesar Ventures' Carolin Gabor called psychiatry's problems as large as they are overlooked, and said few founders bring the passion to it that Aisel's team does.

The fresh capital will go toward expanding Aisel's clinical and engineering teams and funding a UK market entry, converting an existing pipeline in private psychiatry ahead of a planned seed round. The underlying goal, as Houen puts it, is to hand clinicians everything relevant about a patient exactly when they need it — something no human memory can reliably do on its own — and use that to chip away at waiting lists that have defined psychiatric care for too long.

My take — AI-written commentary, not fact-checked reporting

Every healthcare AI pitch lately seems to start with a scribe, because transcription is the easy, demoable part. Aisel's bet is more interesting precisely because it's harder to demo: context and continuity don't fit neatly into a five-minute pitch, but they're the actual bottleneck clinicians describe. A €1.7 million pre-seed round won't fix psychiatry's waiting lists on its own, but funding the unglamorous problem instead of the flashy one is the right instinct, and healthcare investors should be asking more startups why they're building faster typewriters instead of better memory.

Read more about this at: Tech.eu

Related stories

The daily briefing

Every AI story that matters, in your inbox by 8am.

TLDRocket reads all relevant sources, removes duplicate coverage, and summarises the day in two minutes. Follow companies and topics for alerts, or get the briefing in Slack. Free, no spam, unsubscribe anytime.